Cencora to buy American Oncology Network
Plus: Elevance Q3 ratio improves, membership shrinks. The day's rules, money, and enforcement, sourced and tiered below.
Plus: Elevance Q3 ratio improves, membership shrinks. The day's rules, money, and enforcement, sourced and tiered below.
|
American Health Intel
Rules · Money · Medicine · Decoded daily
|
| The Ledger |
Wednesday, October 21, 2026 |
|
|
Cencora to buy American Oncology Network
|
|
Plus: Elevance Q3 ratio improves, membership shrinks. The day's rules, money, and enforcement, sourced and tiered below.
|
|
|
Deal Confidence: High
Cencora, the drug wholesaler, will buy American Oncology Network, a physician-led cancer care network of 350+ providers in 21 states, at a $2.4B enterprise value.
$2.3B at closing plus up to $100M in contingent value rights. If holders roll over 25%, Cencora pays about $1.7B for 75%. It owns about 4% now. Closing date not stated.
|
Why it matters
A drug wholesaler is moving deeper into running cancer practices, which can shift who has leverage when drug prices and contracts are negotiated. Watch for the closing timeline and any antitrust review, neither of which is stated.
|
|
|
Earnings Confidence: High
UPDATE: Elevance, the health insurer, posted a 90.6% Q3 benefit expense ratio, down from 91.3%, and now sees 2026 adjusted EPS of at least $29.00.
Revenue rose just 0.7% to $50.4B. Medicare Advantage members fell 15.5% to 1.9M, Medicaid 4.9% to 8.2M. Nine-month results carry a $935M CMS risk adjustment charge. QUOTE: https://x.com/amhealthintel/status/2112264525219332135
|
Why it matters
The insurer's medical cost ratio improved on a smaller, repriced book rather than on revenue growth. Watch whether membership losses in Medicare Advantage and Medicaid continue.
|
|
|
Also today
Hologic to buy Reveal Genomics Read
|
1046 Records | $62.4B Enforcement | 44 Deadlines | 297 Rules |
|
|
Pick your field on the site and every story tells you what it means for you.
|
|
Reply to this email and tell us what you want covered. We read everything.
|
|
We show our work. We score our own calls.
News and analysis, not legal, medical, coding, or investment advice.
You subscribed at americanhealthintel.com · Unsubscribe
|
|